Non-steroidal anti-inflammatory drugs: use and co-treatment with potentially interacting medications in the elderly.
BACKGROUND
Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used in the elderly. NSAIDs may cause a series of adverse drug reactions, of which gastrointestinal, renovascular/cardiovascular and bleeding complications are of particular concern. Concomitant use of several other drugs may further increase the risk of these adverse effects.


OBJECTIVE
To examine the extent of chronic use of NSAIDs and co-prescription of drugs which may seriously interact with NSAIDs in elderly subjects, by using data from the Norwegian Prescription Database.


RESULTS
A total of 7.3% of all individuals (71,681/984,457) over 60 years of age filled at least one prescription for reimbursed NSAIDs during the 1-year study period (2006). Co-prescription of medications which may interact with NSAIDs was prevalent for drugs used for hypertension and/or heart failure (59.5%), antithrombotic drugs (35.1%), systemic glucocorticoids (12.9%) and SSRI antidepressants (8.3%). As many as 4.8 and 3.8% of NSAID users were co-prescribed warfarin or oral methotrexate respectively.


CONCLUSIONS
The frequent co-prescription of medications which may cause detrimental interactions in elderly chronic NSAID users adds to safety concerns regarding this widely prescribed class of drugs.
Vandraas
Kathrine F
KF
Department of Laboratory Medicine, Children's and Women's Health, Norwegian University of Science and Technology, Trondheim, Norway.
Spigset
Olav
O
Mahic
Milada
M
Slørdal
Lars
L
D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D016208:Databases, Factual; D004347:Drug Interactions; D006801:Humans; D006973:Hypertension / Q000139:chemically induced / Q000188:drug therapy; D009664:Norway; D012306:Risk
D000894:Anti-Inflammatory Agents, Non-Steroidal
BMJ. 2005 Jun 11;330(7504):1370
15947399
BMJ. 2001 Nov 24;323(7323):1236-9
11719417
Arch Intern Med. 1993 Jul 26;153(14):1665-70
8333804
J Clin Pharmacol. 1991 Jul;31(7):588-98
1894754
Lancet. 2004 May 29;363(9423):1751-6
15172772
BMJ. 1995 Apr 1;310(6983):827-30
7711618
Arch Intern Med. 1993 Feb 22;153(4):477-84
8435027
BMJ. 2004 Dec 4;329(7478):1317
15561731
Arch Intern Med. 2000 Mar 27;160(6):777-84
10737277
Am J Gastroenterol. 2000 Sep;95(9):2218-24
11007221
Epidemiology. 2003 Mar;14(2):240-6
12606892
J Rheumatol Suppl. 1991 Mar;28:6-10
2038014
Eur J Clin Pharmacol. 2007 Apr;63(4):403-8
17347805
Eur J Clin Pharmacol. 2001 Apr;57(1):71-5
11372596
Br J Clin Pharmacol. 1993 May;35(5):455-9
8512757
J Clin Invest. 2001 Jul;108(1):7-13
11435450
JAMA. 1994 Sep 14;272(10):781-6
8078142
Arch Intern Med. 2005 Jan 24;165(2):189-92
15668365
Ann Intern Med. 1994 Aug 15;121(4):289-300
8037411
Arch Intern Med. 1998 May 25;158(10):1108-12
9605782
Gut. 2003 Apr;52(4):600-8
12631678
Arch Intern Med. 2002 Feb 11;162(3):265-70
11822918